By Finance Pulse in Stock Market —

Neumora Therapeutics Plummets After Drug Trial Failure

Neumora Therapeutics shares hit rock bottom after its depression drug failed in a Phase 3 trial. Discover the impact on the company's stock and future prospects.

A dramatic downward graph with a background of stock market indicators, symbolizing the plunge in Ne
Neumora Therapeutics Plummets After Drug Trial Failure

Neumora Therapeutics shares plunged to an all-time low after its depression drug failed in a Phase 3 trial.

Source